{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:24:30Z","timestamp":1790774670522,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.intimp.2023.110621","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T17:18:58Z","timestamp":1689009538000},"page":"110621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Potential clinical value of serum interleukin-41 levels in patients with acute gout"],"prefix":"10.1016","volume":"122","author":[{"given":"Yinxin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiudi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-0096","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110621_b0005","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.intimp.2023.110621_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114175","article-title":"Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail","volume":"158","author":"Wu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2023.110621_b0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.maturitas.2014.05.001","article-title":"Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities","volume":"78","author":"Robinson","year":"2014","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.intimp.2023.110621_b0020","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110621_b0025","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet (London, England)."},{"issue":"3s","key":"10.1016\/j.intimp.2023.110621_b0030","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","article-title":"Gout epidemiology and comorbidities","volume":"50","author":"Singh","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.intimp.2023.110621_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.curtheres.2013.04.003","article-title":"A revised estimate of the burden of illness of gout","volume":"75","author":"Wertheimer","year":"2013","journal-title":"Curr. Ther. Res. Clin. Exp."},{"issue":"1","key":"10.1016\/j.intimp.2023.110621_b0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semarthrit.2015.02.004","article-title":"The economic burden of gout: A systematic review","volume":"45","author":"Rai","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.intimp.2023.110621_b0045","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s40273-015-0288-5","article-title":"A systematic review of the economic and humanistic burden of gout","volume":"33","author":"Shields","year":"2015","journal-title":"Pharmacoeconomics."},{"key":"10.1016\/j.intimp.2023.110621_b0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.puhe.2020.06.029","article-title":"Gout in china, 1990\u20132017: the global burden of disease study 2017","volume":"191","author":"Tang","year":"2021","journal-title":"Public Health."},{"issue":"1","key":"10.1016\/j.intimp.2023.110621_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","article-title":"Uric acid as a danger signal in gout and its comorbidities","volume":"9","author":"Rock","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"17","key":"10.1016\/j.intimp.2023.110621_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/nu14173525","article-title":"Gout and diet: A comprehensive review of mechanisms and management","volume":"14","author":"Zhang","year":"2022","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.intimp.2023.110621_b0065","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110621_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2020.105092","article-title":"The role of interleukin-1 family members in hyperuricemia and gout","volume":"88","author":"Kl\u00fcck","year":"2021","journal-title":"Joint Bone Spine"},{"issue":"9","key":"10.1016\/j.intimp.2023.110621_b0075","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10067-015-3109-5","article-title":"IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response","volume":"35","author":"Zeng","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110621_b0080","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/annrheumdis-2019-216233","article-title":"Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout","volume":"79","author":"Kl\u00fcck","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2023.110621_b0085","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/art.39318","article-title":"Gout is a chronic inflammatory disease in which high levels of interleukin-8 (CXCL8), myeloid-related protein 8\/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease","volume":"67","author":"Kienhorst","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110621_b0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/03009742.2012.726372","article-title":"IL-8 -251T\/A and IL-12B 1188A\/C polymorphisms are associated with gout in a Chinese male population","volume":"42","author":"Liu","year":"2013","journal-title":"Scand. J. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110621_b0095","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.semarthrit.2020.06.015","article-title":"Advances in our understanding of gout as an auto-inflammatory disease","volume":"50","author":"Bodofsky","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.intimp.2023.110621_b0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jbspin.2020.05.001","article-title":"Recommendations from the french society of rheumatology for the management of gout: Management of acute flares","volume":"87","author":"Latourte","year":"2020","journal-title":"Joint Bone Spine."},{"issue":"4","key":"10.1016\/j.intimp.2023.110621_b0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cns.12219","article-title":"Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression","volume":"20","author":"Li","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2023.110621_b0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/aps.2016.9","article-title":"Metrnl: a secreted protein with new emerging functions","volume":"37","author":"Zheng","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.intimp.2023.110621_b0115","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.2337\/db15-0274","article-title":"Adipocyte metrnl antagonizes insulin resistance through PPAR\u03b3 signaling","volume":"64","author":"Li","year":"2015","journal-title":"Diabetes."},{"issue":"2","key":"10.1016\/j.intimp.2023.110621_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2014.11.006","article-title":"METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages","volume":"156","author":"Ushach","year":"2015","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110621_b0125","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","article-title":"Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis","volume":"157","author":"Rao","year":"2014","journal-title":"Cell."},{"issue":"12","key":"10.1016\/j.intimp.2023.110621_b0130","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41401-020-00529-9","article-title":"Involvement of the secreted protein Metrnl in human diseases","volume":"41","author":"Miao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2023.110621_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.938341","article-title":"Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile","volume":"13","author":"Ding","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110621_b0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jcmm.13915","article-title":"Serum metrnl is associated with the presence and severity of coronary artery disease","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"7","key":"10.1016\/j.intimp.2023.110621_b0145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/ecco-jcc\/jjz001","article-title":"The Adipokine metrnl ameliorates chronic colitis in Il-10-\/- mice by attenuating mesenteric adipose tissue lesions during spontaneous colitis","volume":"13","author":"Zuo","year":"2019","journal-title":"J. Crohns Colitis."},{"key":"10.1016\/j.intimp.2023.110621_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108253","article-title":"The novel cytokine Metrnl\/IL-41 is elevated in Psoriatic Arthritis synovium and inducible from both entheseal and synovial fibroblasts","volume":"208","author":"Bridgewood","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110621_b0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cca.2022.11.021","article-title":"Increased serum IL-41 is associated with disease activity in rheumatoid arthritis","volume":"538","author":"Gong","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.intimp.2023.110621_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123480","article-title":"Exercise inhibits NLRP3 inflammasome activation in obese mice via the anti-inflammatory effect of meteorin-like","volume":"10","author":"Javaid","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.intimp.2023.110621_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114118","article-title":"Exercise induced meteorin-like protects chondrocytes against inflammation and pyroptosis in osteoarthritis by inhibiting PI3K\/Akt\/NF-\u03baB and NLRP3\/caspase-1\/GSDMD signaling","volume":"158","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.intimp.2023.110621_b0170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41584-019-0280-0","article-title":"Defining remission in patients with gout","volume":"15","author":"Bardin","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"Suppl2 02","key":"10.1016\/j.intimp.2023.110621_b0175","doi-asserted-by":"crossref","first-page":"i86","DOI":"10.1136\/annrheumdis-2011-200618","article-title":"Defining remission in rheumatoid arthritis","volume":"71","author":"Felson","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2023.110621_b0180","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3899\/jrheum.190386","article-title":"Is Remission a Valid Target for Gout?","volume":"47","author":"Pascual","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110621_b0185","article-title":"The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110621_b0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12944-020-1197-y","article-title":"The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study","volume":"19","author":"Liang","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"12","key":"10.1016\/j.intimp.2023.110621_b0195","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/s41401-020-0368-8","article-title":"Metrnl deficiency decreases blood HDL cholesterol and increases blood triglyceride","volume":"41","author":"Qi","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2023.110621_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101747","article-title":"Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP\/PKA\/SIRT1 pathway","volume":"37","author":"Hu","year":"2020","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110621_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0147-5","article-title":"METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPAR\u03b4-dependent pathways in skeletal muscle of mice","volume":"50","author":"Jung","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2023.110621_b0210","doi-asserted-by":"crossref","first-page":"1098570","DOI":"10.3389\/fimmu.2023.1098570","article-title":"Meteorin-like\/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: A comprehensive review of preclinical and clinical studies","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:25:31Z","timestamp":1736432731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923009463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":42,"alternative-id":["S1567576923009463"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110621","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential clinical value of serum interleukin-41 levels in patients with acute gout","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110621"}}